Top Stories
Top Stories

Cramer’s homework uncovers 'buy' into weakness

When Cramer tells a caller he needs to do homework, he ain't kidding.

Following is Cramer's research or homework on stocks recently called to his attention by investors who called into the TV show.

On October 23rd Don in New York asked about Abaxis.

According to Cramer's notes, Abaxis sells point-of-care blood analyzers, which provide clinicians with rapid blood tests for both humans and animals. As a result doctors and vets can run real time lab tests in their office instead of sending them out.

"It's a great idea, but the latest quarter was far from great," said Cramer. The company missed on both earnings and revenues, and they had inventory issues. Too many red flags here. I say stay away from Abaxis for now."

Tooga | Getty Images

Also on October 23rd Jill in Pennsylvania asked about Pitney Bowes.

After sifting through piles of research Cramer said, "Pitney Bowes is transforming itself into a digital communications company. I think if we get more signs that the transformation is sustainable, Pitney Bowes can move higher into the end of the year."

On October 25th Jerry in Florida asked about BJ's Restaurants.

Research shows that BJ's has been struggling, with shares falling from $55 at their 2012 highs to $27.

"This casual pizza and beer chain used to be a nice regional to national growth story, but the company's hit multiple speed-bumps in recent years. No matter how many new restaurants you put up, the market won't care if the existing ones aren't doing well—and they aren't," Cramer said. Last quarter the same store sales were down 2.2%. I say stay away."

Read More from Mad Money with Jim Cramer
Cramer: Deceptive bubble forming in market
Top CEO lands on Wall of Shame
Cisco's stealth message

On November 1st Brett in New Jersey asked about NCR.

"I think NCR is a well-run company with good management, and I like that they're moving toward less hardware and more software and services, with a special emphasis on mobile," Cramer said. The weakness in the quarter mostly came from softness in the legacy ATM business and retail point-of-sale software. Those issues could be here to stay, but I like NCR's vision, and I think the company has a solid and conservative growth trajectory, so I say this stock is a buy into the current weakness."

Call Cramer: 1-800-743-CNBC

Questions for Cramer?

Questions, comments, suggestions for the "Mad Money" website?